Gamunex-c 40 gram/400 ML vial 400ML
Ended Awarded
- Contract number
- SPE2DB26FX4MY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,926
Award facts
- Contract value 100% obligated
- $27,926.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $27,926.40 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of GAMUNEX-C 40 gram/400 mL vials with a completion date of December 2, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. GAMUNEX-C is an intravenous immunoglobulin (IVIG) product used to treat various immunodeficiency conditions and autoimmune disorders, making it a critical medical supply for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices. AmerisourceBergen Drug Corp serves as a key vendor for the Defense Health Agency and other federal healthcare systems through this flexible contract vehicle, which positions the company to fulfill critical medical procurement requirements across multiple therapeutic domains for military and veteran populations.
Quick answers
Who was awarded contract SPE2DB26FX4MY?
SPE2DB26FX4MY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FX4MY worth?
The government has obligated $27,926 on SPE2DB26FX4MY.
Is contract SPE2DB26FX4MY an order under another contract?
Yes. SPE2DB26FX4MY is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4MY competed?
The extent of competition for SPE2DB26FX4MY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award